Cargando…

Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases

INTRODUCTION: Impaired high-density lipoprotein (HDL) levels and antioxidant functionality of HDL, mainly attributed to a decreased paraoxonase-1 (PON1) functionality, have been described in autoimmune conditions. In this setting, a role for humoral response in cardiovascular disease is emerging. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Carrio, Javier, Mozo, Lourdes, López, Patricia, Nikiphorou, Elena, Suárez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925573/ https://www.ncbi.nlm.nih.gov/pubmed/29740582 http://dx.doi.org/10.3389/fmed.2018.00114

Ejemplares similares

IgG Anti-high-Density Lipoproteins Antibodies Discriminate Between Arterial and Venous Events in Thrombotic Antiphospholipid Syndrome Patients
por: Sciascia, Savino, et al.
Publicado: (2019)

A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients
por: López, Patricia, et al.
Publicado: (2016)

IgG Anti-High Density Lipoprotein Antibodies Are Elevated in Abdominal Aortic Aneurysm and Associated with Lipid Profile and Clinical Features
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2019)

Relationship Between T-Cell Exosomes and Cellular Subsets in SLE According to Type I IFN-Signaling
por: López, Patricia, et al.
Publicado: (2020)

High Density Lipoproteins: Metabolism, Function, and Therapeutic Potential
por: Jomard, Anne, et al.
Publicado: (2020)

High Density Lipoprotein and it’s Dysfunction
por: Eren, Esin, et al.
Publicado: (2012)

Larrea divaricata: anti-inflammatory and antioxidant effects of on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005)

Common and Specific Associations of Anti-SSA/Ro60 and Anti-Ro52/TRIM21 Antibodies in Systemic Lupus Erythematosus
por: Menéndez, Aurora, et al.
Publicado: (2013)

The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Predicting the Severity of Proteinuria and Renal Dysfunction in Primary Nephrotic Syndrome
por: Yılmaz Aydın, Fatma, et al.
Publicado: (2021)

Correction: Larrea divaricata: anti-inflammatory and antioxidant effects on macrophages and low density lipoproteins
por: Peralta, Ignacio, et al.
Publicado: (2022)

Case Report: Lipoprotein Glomerulopathy Complicated by Atypical Hemolytic Uremic Syndrome
por: Kollbrunner, Lara, et al.
Publicado: (2021)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

Comorbidities in Spondyloarthritis
por: Moltó, Anna, et al.
Publicado: (2018)

Obesity-Associated Metabolic Disturbances Reverse the Antioxidant and Anti-Inflammatory Properties of High-Density Lipoproteins in Microglial Cells
por: Grao-Cruces, Elena, et al.
Publicado: (2021)

Standardization of a Method to Evaluate the Antioxidant Capacity of High-Density Lipoproteins
por: de Juan-Franco, Elena, et al.
Publicado: (2009)

High-Density Lipoprotein Function and Dysfunction in Health and Disease
por: Chiesa, Scott T., et al.
Publicado: (2019)

Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies
por: Nilsson, Isabell, et al.
Publicado: (2020)

Crosstalk between high-density lipoproteins and endothelial cells in health and disease: Insights into sex-dependent modulation
por: Dietrich, Elisa, et al.
Publicado: (2022)

Inverse association between low-density lipoprotein cholesterol and bone mineral density in young- and middle-aged people: The NHANES 2011–2018
por: Xiao, Fangjun, et al.
Publicado: (2022)

Editorial: Comorbidity Burden in Rheumatic Diseases
por: Nikiphorou, Elena, et al.
Publicado: (2018)

High-Density Lipoprotein – A Hero, a Mirage, or a Witness?
por: Sviridov, Dmitri
Publicado: (2014)

Low-Density Lipoprotein Receptor-Related Protein-1 Signaling in Angiogenesis
por: Mao, Hua, et al.
Publicado: (2017)

Association of the Monocyte–to–High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy
por: Tang, Xixiang, et al.
Publicado: (2021)

A Novel Anti-Inflammatory Effect for High Density Lipoprotein
por: Cameron, Scott J., et al.
Publicado: (2015)

Non-Cirrhotic Portal Hypertension in Systemic Lupus Erythematosus
por: Suárez-Díaz, Silvia, et al.
Publicado: (2023)

Endothelial lipase increases antioxidative capacity of high-density lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2019)

Dietary-Induced Elevations of Triglyceride-Rich Lipoproteins Promote Atherosclerosis in the Low-Density Lipoprotein Receptor Knockout Syrian Golden Hamster
por: Lin, Xiao, et al.
Publicado: (2021)

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
por: Salazar, Juan, et al.
Publicado: (2015)

Anticipatory Role of High Density Lipoprotein and Endothelial Dysfunction: An Overview
por: Eren, Esin, et al.
Publicado: (2014)

Dysfunctional high-density lipoprotein in chronic inflammatory rheumatic diseases
por: Waldecker-Gall, Sabina, et al.
Publicado: (2023)

Achieved low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio predicts the pathophysiological evolution of lipid-rich plaques in acute coronary syndromes: an optical coherence tomography study
por: He, Luping, et al.
Publicado: (2023)

Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs
por: López, Patricia, et al.
Publicado: (2006)

Circulating Oxidized Low-Density Lipoproteins and Antibodies against Oxidized Low-Density Lipoproteins as Potential Biomarkers of Colorectal Cancer
por: Diakowska, Dorota, et al.
Publicado: (2015)

The Dual Role of Low-Density Lipoprotein Receptor-Related Protein 1 in Atherosclerosis
por: Chen, Jiefang, et al.
Publicado: (2021)

Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies
por: Jin, Xiao, et al.
Publicado: (2022)

Emerging Non-statin Treatment Options for Lowering Low-Density Lipoprotein Cholesterol
por: Bardolia, Chandni, et al.
Publicado: (2021)

High Density Lipoprotein-Based Therapeutics: Novel Mechanism of Probucol in Foam Cells
por: Hafiane, Anouar, et al.
Publicado: (2022)

The Role of High-Density Lipoprotein in Lowering Risk of Dementia in the Elderly: A Review
por: Anusheel,, et al.
Publicado: (2022)

Impact of low-density lipoprotein cholesterol on progression of aortic valve sclerosis and stenosis
por: Seo, Jeong Hun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8dlba8rvm6efut7d19aoq02ts9